| Estimation of the percentage of US patients with cancer who benefit from genome-driven oncology J Marquart, EY Chen, V Prasad JAMA oncology 4 (8), 1093-1098, 2018 | 331 | 2018 |
| An overview of cancer drugs approved by the US Food and Drug Administration based on the surrogate end point of response rate EY Chen, V Raghunathan, V Prasad JAMA internal medicine 179 (7), 915-921, 2019 | 140 | 2019 |
| Estimation of study time reduction using surrogate end points rather than overall survival in oncology clinical trials EY Chen, SK Joshi, A Tran, V Prasad JAMA internal medicine 179 (5), 642-647, 2019 | 100 | 2019 |
| Therapeutic delays lead to worse survival among patients with hepatocellular carcinoma AG Singal, AK Waljee, N Patel, EY Chen, JA Tiro, JA Marrero, AC Yopp Journal of the National Comprehensive Cancer Network 11 (9), 1101-1108, 2013 | 78 | 2013 |
| Does delay of adjuvant chemotherapy impact survival in patients with resected stage II and III colon adenocarcinoma? UD Bayraktar, E Chen, S Bayraktar, LR Sands, F Marchetti, AJ Montero, ... Cancer 117 (11), 2364-2370, 2011 | 75 | 2011 |
| FDA acceptance of surrogate end points for cancer drug approval: 1992-2019 EY Chen, A Haslam, V Prasad JAMA internal medicine 180 (6), 912-914, 2020 | 72 | 2020 |
| Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study JJ Harding, J Fan, DY Oh, HJ Choi, JW Kim, HM Chang, L Bao, HC Sun, ... The Lancet Oncology 24 (7), 772-782, 2023 | 50 | 2023 |
| Knowledge and attitudes about hepatitis C virus (HCV) infection and its treatment in HCV mono‐infected and HCV/HIV co‐infected adults EY Chen, CS North, O Fatunde, I Bernstein, S Salari, B Day, MK Jain Journal of viral hepatitis 20 (10), 708-714, 2013 | 43 | 2013 |
| A small percentage of patients with hepatitis C receive triple therapy with boceprevir or telaprevir EY Chen, SN Sclair, F Czul, B Apica, P Dubin, P Martin, WM Lee Clinical Gastroenterology and Hepatology 11 (8), 1014-1020. e2, 2013 | 38 | 2013 |
| Hepatitis E masquerading as drug‐induced liver injury EY Chen, K Baum, W Collins, A Löve, M Merz, S Olafsson, ES Björnsson, ... Hepatology 56 (6), 2420-2423, 2012 | 29 | 2012 |
| A phase II study of celecoxib with irinotecan, 5-fluorouracil, and leucovorin in patients with previously untreated advanced or metastatic colorectal cancer EY Chen, CD Blanke, DG Haller, AB Benson, T Dragovich, HJ Lenz, ... American journal of clinical oncology 41 (12), 1193-1198, 2018 | 26 | 2018 |
| Small bowel adenocarcinoma EY Chen, GM Vaccaro Clinics in colon and rectal surgery 31 (05), 267-277, 2018 | 25 | 2018 |
| Censored patients in Kaplan–Meier plots of cancer drugs: An empirical analysis of data sharing K Rosen, V Prasad, EY Chen European Journal of Cancer 141, 152-161, 2020 | 19 | 2020 |
| Circulating hybrid cells: a novel liquid biomarker of treatment response in gastrointestinal cancers BS Walker, TL Sutton, L Zarour, JG Hunter, SG Wood, VL Tsikitis, ... Annals of surgical oncology 28 (13), 8567-8578, 2021 | 15 | 2021 |
| Estimation of US patients with cancer who may respond to cytotoxic chemotherapy EB Maldonado, S Parsons, EY Chen, A Haslam, V Prasad Future science OA 6 (8), FSO600, 2020 | 14 | 2020 |
| Effect of time to surgery of colorectal liver metastases on survival EY Chen, SC Mayo, T Sutton, MR Kearney, A Kardosh, GM Vaccaro, ... Journal of Gastrointestinal Cancer 52, 169-176, 2021 | 13 | 2021 |
| Preoperative docetaxel/cisplatin/5-fluorouracil chemotherapy in patients with locally advanced gastro-esophageal adenocarcinoma UD Bayraktar, S Bayraktar, P Hosein, E Chen, LG Koniaris, ... Medical Oncology 29, 1707-1710, 2012 | 12 | 2012 |
| Surgical and oncologic outcomes following repeat hepatic resection of colorectal liver metastasis: Who benefits? LH Wong, TL Sutton, BS Walker, CD Lopez, A Kardosh, RL Eil, EY Chen, ... The American Journal of Surgery 221 (6), 1114-1118, 2021 | 11 | 2021 |
| pAKT expression and response to sorafenib in differentiated thyroid cancer M Yarchoan, C Ma, AB Troxel, SJ Stopenski, W Tang, AB Cohen, ... Hormones and Cancer 7, 188-195, 2016 | 11 | 2016 |
| Geographic disparities in referral rates and oncologic outcomes of intrahepatic cholangiocarcinoma: a population-based study TL Sutton, BS Walker, N Nabavizadeh, A Grossberg, CR Thomas Jr, ... Annals of surgical oncology 28 (13), 8152-8159, 2021 | 10 | 2021 |
Vinay Prasad, MD MPHProfessor, University of California San FranciscoVerified email at ucsf.edu
